Sana Biotechnology Stock Quote SANA - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

6.25

Bid

6.27

Ask

6.74

Volume

1,358,288

6.15 Day's Range 6.61

2.745 52 Week Range 12.00

Market Cap

1.384B

Previous Close

6.05

Open

6.25

Last Trade

200

6.25

(formt)

Last Trade Time

Financial Volume

$ 8,578,464

VWAP

6.3156

Average Volume (3m)

1,947,582

Shares Outstanding

221,502,908

Dividend Yield

PE Ratio

-5.00

Earnings Per Share (EPS)

-1.28

Revenue

Net Profit

-283.26M

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. Its operations include identifying and developing potential product candidates, executing preclinical studies, establishing manufacturing capabilities, acquiring tec... Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. Its operations include identifying and developing potential product candidates, executing preclinical studies, establishing manufacturing capabilities, acquiring technology, organizing and staffing the Company, business planning, establishing the company's intellectual property portfolio, raising capital, and providing general and administrative support for these operations. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.sana.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Sana Biotechnology Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker SANA. The last closing price for Sana Biotechnology was $6.05. Over the last year, Sana Biotechnology shares have traded in a share price range of $ 2.745 to $ 12.00.

Sana Biotechnology currently has 221,502,908 shares outstanding. The market capitalization of Sana Biotechnology is $1.34 billion. Sana Biotechnology has a price to earnings ratio (PE ratio) of -5.00.

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington’s Disease and Other Glia

Healthy transplanted human glial cells replaced diseased glial cells in the brains of human glial chimeric Huntingtin mice Additional proof-of-concept for the advancement of SC379, Sana’s...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.36	6.11205432937	5.89	6.61	5.695	1279684	6.07034521	CS
4	0.83	15.3136531365	5.42	7.4	4.93	2109116	5.90471029	CS
12	-3.75	-37.5	10	10.5	4.93	1947582	6.83696049	CS
26	0.84	15.5268022181	5.41	12	4.93	1962716	7.74159309	CS
52	0.36	6.11205432937	5.89	12	2.745	1976491	6.44779109	CS
156	-12.35	-66.3978494624	18.6	26.6	2.745	1425507	7.54507988	CS
260	-31.65	-83.5092348285	37.9	44.6	2.745	1304575	8.60906688	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	260.07k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.61M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M